期刊文献+

中国汉族原发性高血压候选基因研究进展 被引量:4

Candidate Genes of Essential Hypertension in Chinese Han Population
下载PDF
导出
摘要 原发性高血压是遗传物质与环境共同作用的多基因遗传病,发病率高,危害严重。对其候选基因的研究是阐明其发病机制的基础,也预示着高血压基因治疗的广阔前景,目前候选基因策略的关联分析仍是主流的研究方法。许多研究显示,原发性高血压易感基因的作用在不同人种、民族有显著差异,文章主要针对以中国汉族为对象的,涉及肾素-血管紧张素等系统多个基因及其协同作用的研究进展予以综述。 Essential hypertension is a polygenic disorder with genetic and environmental factors contributing to its high incidence and severe sequences. Studies about its candidate genes is the basis to elucidate its pathogenesiso, which signifies a bright future of gent therapy to essential hypertension. The correlation analysis of the strategy for eandidate gene is the main approach at present. A lot of researches have revealed that the tmderlying genetic pathways of essential hypertension vary with ethnieity and nationality signifieantly. Therefore ,the studies about essential hypertension candidate genes concerning different mechanisms as reninangiotensin system and the gene-gene interaction in Chinese han population are reviewed in this article.
出处 《医学综述》 2008年第8期1158-1161,共4页 Medical Recapitulate
关键词 原发性高血压 候选基因 汉族 协同作用 Essential hypertension Candidate genes Han population Gene-gene interaction
  • 相关文献

参考文献22

二级参考文献161

共引文献135

同被引文献40

  • 1贾春蓉,王文娟.益肾法对原发性高血压患者血管内皮细胞NO-NOS系统的影响[J].河北中医药学报,2016,31(2):9-10. 被引量:3
  • 2吴铁吉.我国儿童高血压的临床流行病学[J].中国实用儿科杂志,2004,19(8):449-451. 被引量:27
  • 3颜慕霞,顾晓琼.正常儿童ACE基因多态性与血清ACE活性的关系[J].广东医学,2006,27(1):100-101. 被引量:6
  • 4潘正军,王振平,陈忠科.妊娠期高血压疾病病因探析[J].中国实用妇科与产科杂志,2007,23(6):465-467. 被引量:36
  • 5Gong M,Hubner N.Molecular genetics of human hypertension[J].Clin Sci (Lond),2006,110 (3):315-326.
  • 6Doris P A.Hypertension genetics,single nucleotide polymorphisms,and the common disease:common variant hypothesis[J].Hypertension,2002,39 (2 Pt 2):323-331.
  • 7May A,Wang T J.Biomarkers for cardiovascular disease:challenges and future directions[J].Trends Mol Med,2008,14 (6):261-267.
  • 8Andreadis E A,Georgiopoulos D X,Tzavara C K,et al.Plasma brain natriuretic peptide:a biochemical marker of effective blood pressure management[J].J Hypertens,2009,27(2):425-432.
  • 9Bettencourt P M.Clinical usefulness of B-type natriuretic peptide measurement:present and future perspectives[J].Heart,2005,91(11):1489-1494.
  • 10McKie P M,Rodeheffer R J,Cataliotti A,et al.Amino-terminal pro-B-type natriuretic peptide and b-type natriuretic peptide:biomarkers for mortality in a large community-based cohort free of heart failure[J].Hypertension,2006,47 (5):874-880.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部